COVID-19 pandemic in French Guiana
Impact of the COVID-19 pandemic in French Guiana
The COVID-19 pandemic in French Guiana is part of the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus was confirmed to have reached French Guiana, an overseas region of France, in March 2020.
Background
The COVID-19 pandemic began in Wuhan, China, in December 2019. The World Health Organization declared a Public Health Emergency of International Concern on 30 January 2020, and a pandemic on 11 March 2020. French Guiana, located on the northeastern coast of South America, shares borders with Brazil and Suriname, making it vulnerable to cross-border transmission.
Timeline
2020
The first cases of COVID-19 in French Guiana were reported in March 2020. The initial cases were linked to travelers returning from France. As the number of cases increased, the local government implemented measures such as lockdowns and curfews to control the spread of the virus.
2021
In 2021, French Guiana experienced several waves of infections, with peaks in cases leading to increased pressure on the healthcare system. Vaccination campaigns were launched to curb the spread of the virus, with efforts to reach remote communities.
2022
By 2022, the situation in French Guiana had stabilized somewhat, with vaccination rates improving and public health measures being adjusted according to the epidemiological situation.
Impact
Healthcare System
The pandemic placed significant strain on French Guiana's healthcare system, which had to manage the influx of COVID-19 patients while maintaining other essential health services. The Centre Hospitalier de Cayenne played a crucial role in treating COVID-19 patients.
Economy
The economic impact of the pandemic was profound, affecting sectors such as tourism, trade, and local businesses. The government provided financial support to mitigate the economic downturn.
Society
The pandemic affected daily life in French Guiana, with restrictions on movement and gatherings. Educational institutions adapted by implementing remote learning where possible.
Government Response
The government of French Guiana, in coordination with the French government, implemented various public health measures, including testing, contact tracing, and vaccination campaigns. Efforts were made to communicate effectively with the public to ensure compliance with health guidelines.
Vaccination
Vaccination efforts in French Guiana were part of the broader French vaccination strategy. The government prioritized vulnerable populations and healthcare workers, with vaccines being distributed through local health centers and mobile units.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD